查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
多血小板血漿(PRP)的全球市場預測(～2028年):各來源(同族，自體)、用途(整形外科，脊椎外科，腦神經外科)、終端用戶、地區的分析
市場調查報告書
商品編碼
1107779

多血小板血漿(PRP)的全球市場預測(～2028年):各來源(同族，自體)、用途(整形外科，脊椎外科，腦神經外科)、終端用戶、地區的分析

Platelet Rich Plasma (PRP) Market Forecasts to 2028 - Global Analysis By Source (Homologous, Autologous), Application (Orthopedic and Spinal Surgery, Neurosurgery), End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

全球多血小板血漿(PRP)的市場規模，預計從2022年的6億1,874萬美元，2028年達到13億4,388萬美元，在預測期間內預計以13.8％的年複合成長率成長。

本報告提供全球多血小板血漿(PRP)市場相關調查分析，市場市場趨勢，各來源，各用途，各終端用戶，各地區的市場分析，再加上主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 簡介
  • 促進因素
  • 阻礙因素
  • 機會
  • 威脅
  • 產品分析
  • 用途分析
  • 終端用戶分析
  • 新興市場
  • COVID-19影響

第4章 波特的五力分析

第5章 全球多血小板血漿(PRP)市場:各來源

  • 簡介
  • 同族
  • 自體
  • 同種異體

第6章 全球多血小板血漿(PRP)市場:各產品

  • 簡介
  • 純粹多血小板纖維蛋白(P-PRF)
  • 純粹多血小板血漿(P-PRP)
  • 多白血球多血小板纖維蛋白(L-PRF)
  • 多血小板血漿設備
  • 多白血球多血小板血漿(L-PRP)
  • 多血小板血漿(PRP)凝膠

第7章 全球多血小板血漿(PRP)市場:各成長因子分子

  • 簡介
  • 表皮成長因子(EGF)
  • 纖維母細胞成長因子-2(FGF-2)
  • 胰島素先生成長因子(IGF)
  • 血小板來源成長因子(PDGF)
  • 血管內皮層生長因子(VEGF)

第8章 全球多血小板血漿(PRP)市場:各用途

  • 簡介
  • 整形外科、脊椎外科
    • 關節炎
    • 慢性肌腱炎
    • 骨的修復、再生
  • 運動醫學
  • 皮膚科、美容外科
    • 整形外科
    • 男性型脫髮症/護髮
    • 潰瘍治癒
  • 心肌損傷
  • 眼科手術
  • 腦神經外科
  • 一般外科
  • 牙科、牙周外科
  • 美學
  • 神經損傷
  • 其他的用途
    • 創傷治療
    • 泌尿科
    • 口腔、顎顏面外科
    • 心臟胸部外科

第9章 全球多血小板血漿(PRP)市場:各終端用戶

  • 簡介
  • 學術、研究機關
  • 醫院
  • 診療室/個人開業醫生
  • 診所
    • 美容、皮膚科、毛髮科診所
    • 整形外科診所
    • 眼科診所

第10章 全球多血小板血漿(PRP)市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東、非洲

第11章 主要發展

  • 契約，夥伴關係，合作，合資企業
  • 收購與合併
  • 新產品的銷售
  • 擴張
  • 其他的重要策略

第12章 企業簡介

  • Zimmer Biomet Holdings Inc
  • Vertical Spine LLC
  • ThermoGenesis Holdings Inc
  • Arthrex Inc
  • Stryker Exactech Inc
  • Regen Lab
  • ISTO Biologics
  • Glofinn Oy
  • EmCyte Corporation
  • DePuy Synthes Companies
  • AdiStem Ltd
  • T-Biotechnology
  • Dr. PRP USA LLC
  • Royal Biologics
Product Code: SMRC21670

According to Stratistics MRC, the Global Platelet Rich Plasma (PRP) Market is accounted for $618.74 million in 2022 and is expected to reach $1,343.88 million by 2028 growing at a CAGR of 13.8% during the forecast period. Platelet-rich plasma treatment uses the platelets by loading its concentration in the injection to improve the healing of different body parts. Platelet-rich plasma (PRP) is proven to be a prominent source of autologous products in the field of regenerative medicine and a true precursor for the healing process along with scaffold and stem cells.

Platelet-rich plasma therapy is witnessing a huge rise in its popularity and acceptance for treating arthritis as it inhibits inflammation, lessens the rate of progression of osteoarthritis, and develops the formation of new cartilage. According to the article published in the Lancet Journal in 2020, osteoarthritis affects 7% of the global population, more than 500 million people worldwide, with women disproportionately affected by the condition. The number of people affected globally rise by 48% from 1990 to 2019, and in 2019 osteoarthritis was the 15th highest cause of years lived with disability (YLDs) worldwide.

Market Dynamics:

Driver:

Increasing cosmetics surgery

The increasing incidence of sports injuries, an increase in the number of cosmetic and surgical treatments, and the increased utilization of platelet-rich plasma in various therapeutic sectors are all augmenting the market's rise. The number of treatments performed has expanded over the last five years, and people's demand for minimally invasive cosmetic surgery has grown across the United States. Liposuction and facelifts are becoming increasingly fashionable.

Restraint:

High prices of plasma therapy

A single platelet-rich plasma treatment will normally cost high. Treatments may need to be repeated at times. Platelet plasma therapy treatment costs vary depending on the provider and the number of injections needed. The cost of treatment varies relying upon its location, facilities, and the expertise of the specialist performing it.

Opportunity:

Technological advancements

Technological advancements in platelet-rich plasma devices have prompted an expansion in the utilization of pure platelet-rich plasma in different situations and with high platelet concentrations. The industry has additionally benefited from technological breakthroughs such as smart home diagnostic kits which are likely to provide ample opportunities for the market.

Threat:

FDA approval in end-use cases

Even though the equipment utilized to produce platelet rich plasma and the injections have been cleared by the FDA (Food and Drug Administration), this method is considered investigational and has not been officially approved by the FDA for some purposes. Outside of orthopedic treatment, platelet rich plasma is being utilized for the treatment of hair loss, skin rejuvenation, and post-surgical healing.

The orthopedic and spinal surgery segment is expected to be the largest during the forecast period

The orthopedic and spinal surgery segment is estimated to have a lucrative growth owing to the increasing number of orthopedic surgeries. As platelet rich plasma mimics the body's natural healing process, companies in the platelet rich plasma market are tapping opportunities in orthopaedics and spinal surgeries.

The pure platelet rich plasma (P-PRP) segment is expected to have the highest CAGR during the forecast period

The pure platelet rich plasma (P-PRP) segment is anticipated to witness the fastest CAGR growth during the forecast period due to the benefits such as accelerated healing process, tissue repair and generation, improvement in overall function, and increased demand across distinct therapeutics industry spaces.

Region with highest share:

North America is projected to hold the largest market share during the forecast period due to the rising awareness about platelet rich plasma treatments, technological advancements, and the increasing number of cosmetics surgeries in the region. Moreover, the presence of supportive regulatory authorities is fuelling the market growth in North America.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period owing to increasing number of cosmetic surgeries to improve facial features in countries, growing medical tourism industry and active involvement of academic and research institutes for evaluating the application of platelet rich plasma therapies.

Key players in the market

Some of the key players profiled in the Platelet Rich Plasma (PRP) Market include Zimmer Biomet Holdings Inc, Vertical Spine LLC, ThermoGenesis Holdings Inc, Arthrex Inc, Stryker Exactech Inc, Regen Lab, ISTO Biologics, Glofinn Oy, EmCyte Corporation, DePuy Synthes Companies, AdiStem Ltd, T-Biotechnology, Dr. PRP USA LLC and Royal Biologics.

Key Developments:

In Sep 2021, Royal Biologics announced FDA 510K approval of their Maxx™- PRP concentration system. Maxx™-PRP is a patented next generation concentration device that can be used to concentrate autologous whole blood, for the safe and rapid preparation of platelet rich plasma to use point of care for mixing with autograft and/or allograft to improve handling characteristics.

In July 2021, Zimmer Biomet Holdings Inc partnered with OSSIS to serve as the exclusive Asia Pacific distributor for its patient-specific 3D printed titanium hip replacement joints. This partnership will allow Zimmer Biomet to provide our extensive network of orthopaedic surgeons with the option of patient-specific implants which are crafted with a combination of clinical and engineering expertise.

Sources Covered:

  • Homologous
  • Autologous
  • Allogeneic

Products Covered:

  • Pure Platelet-Rich Fibrin (P-PRF)
  • Pure Platelet Rich Plasma (P-PRP)
  • Leukocyte-Rich Platelet Rich Fibrin (L-PRF)
  • Platelet-Rich Plasma Instruments
  • Leukocyte Rich Platelet Rich Plasma (L-PRP)
  • Platelet Rich Plasma (PRP) Gel

Growth Factor Molecules Covered:

  • Epidermal Growth Factor (EGF)
  • Fibroblast Growth Factor-2 (FGF-2)
  • Insulin-like Growth Factor (IGF)
  • Platelet-Derived Growth Factor (PDGF)
  • Vascular Endothelial Growth Factor (VEGF)

Applications Covered:

  • Orthopedic and Spinal Surgery
  • Sports Medicine
  • Dermatology & Cosmetic Surgery
  • Cardiac Muscle Injury
  • Ophthalmic Surgery
  • Neurosurgery
  • General Surgery
  • Dentistry/Periodontal Surgery
  • Aesthetics
  • Nerve Injury
  • Other Applications

End Users Covered:

  • Academic & Research Institutes
  • Hospitals
  • Physician's office/Private Practice
  • Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Platelet Rich Plasma (PRP) Market, By Source

  • 5.1 Introduction
  • 5.2 Homologous
  • 5.3 Autologous
  • 5.4 Allogeneic

6 Global Platelet Rich Plasma (PRP) Market, By Product

  • 6.1 Introduction
  • 6.2 Pure Platelet-Rich Fibrin (P-PRF)
  • 6.3 Pure Platelet Rich Plasma (P-PRP)
  • 6.4 Leukocyte-Rich Platelet Rich Fibrin (L-PRF)
  • 6.5 Platelet-Rich Plasma Instruments
  • 6.6 Leukocyte Rich Platelet Rich Plasma (L-PRP)
  • 6.7 Platelet Rich Plasma (PRP) Gel

7 Global Platelet Rich Plasma (PRP) Market, By Growth Factor Molecules

  • 7.1 Introduction
  • 7.2 Epidermal Growth Factor (EGF)
  • 7.3 Fibroblast Growth Factor-2 (FGF-2)
  • 7.4 Insulin-like Growth Factor (IGF)
  • 7.5 Platelet-Derived Growth Factor (PDGF)
  • 7.6 Vascular Endothelial Growth Factor (VEGF)

8 Global Platelet Rich Plasma (PRP) Market, By Application

  • 8.1 Introduction
  • 8.2 Orthopedic and Spinal Surgery
    • 8.2.1 Arthritis
    • 8.2.2 Chronic Tendinitis
    • 8.2.3 Bone Repair and Regeneration
  • 8.3 Sports Medicine
  • 8.4 Dermatology & Cosmetic Surgery
    • 8.4.1 Plastic Surgery
    • 8.4.2 Androgenic Alopecia/Hair Care
    • 8.4.3 Ulcer Healing
      • 8.4.3.1 Venous Ulcer
      • 8.4.3.2 Trophic Ulcer
      • 8.4.3.3 Pyoderma Gangrenosum Ulcer
      • 8.4.3.4 Vasculitic Ulcer
      • 8.4.3.5 Traumatic Ulcer
      • 8.4.3.6 Diabetic Ulcer
  • 8.5 Cardiac Muscle Injury
  • 8.6 Ophthalmic Surgery
  • 8.7 Neurosurgery
  • 8.8 General Surgery
  • 8.9 Dentistry/Periodontal Surgery
  • 8.10 Aesthetics
  • 8.11 Nerve Injury
  • 8.12 Other Applications
    • 8.12.1 Wound Healing
    • 8.12.2 Urology
    • 8.12.3 Oral and Maxillofacial Surgery
    • 8.12.4 Cardiothoracic Surgery

9 Global Platelet Rich Plasma (PRP) Market, By End User

  • 9.1 Introduction
  • 9.2 Academic & Research Institutes
  • 9.3 Hospitals
  • 9.4 Physician's office/Private Practice
  • 9.5 Clinics
    • 9.5.1 Cosmetic/Dermatology/Trichology Clinics
    • 9.5.2 Orthopedic Clinics
    • 9.5.3 Ophthalmic Clinics

10 Global Platelet Rich Plasma (PRP) Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Zimmer Biomet Holdings Inc
  • 12.2 Vertical Spine LLC
  • 12.3 ThermoGenesis Holdings Inc
  • 12.4 Arthrex Inc
  • 12.5 Stryker Exactech Inc
  • 12.6 Regen Lab
  • 12.7 ISTO Biologics
  • 12.8 Glofinn Oy
  • 12.9 EmCyte Corporation
  • 12.10 DePuy Synthes Companies
  • 12.11 AdiStem Ltd
  • 12.12 T-Biotechnology
  • 12.13 Dr. PRP USA LLC
  • 12.14 Royal Biologics

List of Tables

  • Table 1 Global Platelet Rich Plasma (PRP) Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Platelet Rich Plasma (PRP) Market Outlook, By Source (2020-2028) ($MN)
  • Table 3 Global Platelet Rich Plasma (PRP) Market Outlook, By Homologous (2020-2028) ($MN)
  • Table 4 Global Platelet Rich Plasma (PRP) Market Outlook, By Autologous (2020-2028) ($MN)
  • Table 5 Global Platelet Rich Plasma (PRP) Market Outlook, By Allogeneic (2020-2028) ($MN)
  • Table 6 Global Platelet Rich Plasma (PRP) Market Outlook, By Product (2020-2028) ($MN)
  • Table 7 Global Platelet Rich Plasma (PRP) Market Outlook, By Pure Platelet-Rich Fibrin (P-PRF) (2020-2028) ($MN)
  • Table 8 Global Platelet Rich Plasma (PRP) Market Outlook, By Pure Platelet Rich Plasma (P-PRP) (2020-2028) ($MN)
  • Table 9 Global Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte-Rich Platelet Rich Fibrin (L-PRF) (2020-2028) ($MN)
  • Table 10 Global Platelet Rich Plasma (PRP) Market Outlook, By Platelet-Rich Plasma Instruments (2020-2028) ($MN)
  • Table 11 Global Platelet Rich Plasma (PRP) Market Outlook, By Leukocyte Rich Platelet Rich Plasma (L-PRP) (2020-2028) ($MN)
  • Table 12 Global Platelet Rich Plasma (PRP) Market Outlook, By Platelet Rich Plasma (PRP) Gel (2020-2028) ($MN)
  • Table 13 Global Platelet Rich Plasma (PRP) Market Outlook, By Growth Factor Molecules (2020-2028) ($MN)
  • Table 14 Global Platelet Rich Plasma (PRP) Market Outlook, By Epidermal Growth Factor (EGF) (2020-2028) ($MN)
  • Table 15 Global Platelet Rich Plasma (PRP) Market Outlook, By Fibroblast Growth Factor-2 (FGF-2) (2020-2028) ($MN)
  • Table 16 Global Platelet Rich Plasma (PRP) Market Outlook, By Insulin-like Growth Factor (IGF) (2020-2028) ($MN)
  • Table 17 Global Platelet Rich Plasma (PRP) Market Outlook, By Platelet-Derived Growth Factor (PDGF) (2020-2028) ($MN)
  • Table 18 Global Platelet Rich Plasma (PRP) Market Outlook, By Vascular Endothelial Growth Factor (VEGF) (2020-2028) ($MN)
  • Table 19 Global Platelet Rich Plasma (PRP) Market Outlook, By Application (2020-2028) ($MN)
  • Table 20 Global Platelet Rich Plasma (PRP) Market Outlook, By Orthopedic and Spinal Surgery (2020-2028) ($MN)
  • Table 21 Global Platelet Rich Plasma (PRP) Market Outlook, By Arthritis (2020-2028) ($MN)
  • Table 22 Global Platelet Rich Plasma (PRP) Market Outlook, By Chronic Tendinitis (2020-2028) ($MN)
  • Table 23 Global Platelet Rich Plasma (PRP) Market Outlook, By Bone Repair and Regeneration (2020-2028) ($MN)
  • Table 24 Global Platelet Rich Plasma (PRP) Market Outlook, By Sports Medicine (2020-2028) ($MN)
  • Table 25 Global Platelet Rich Plasma (PRP) Market Outlook, By Dermatology & Cosmetic Surgery (2020-2028) ($MN)
  • Table 26 Global Platelet Rich Plasma (PRP) Market Outlook, By Plastic Surgery (2020-2028) ($MN)
  • Table 27 Global Platelet Rich Plasma (PRP) Market Outlook, By Androgenic Alopecia/Hair Care (2020-2028) ($MN)
  • Table 28 Global Platelet Rich Plasma (PRP) Market Outlook, By Ulcer Healing (2020-2028) ($MN)
  • Table 29 Global Platelet Rich Plasma (PRP) Market Outlook, By Cardiac Muscle Injury (2020-2028) ($MN)
  • Table 30 Global Platelet Rich Plasma (PRP) Market Outlook, By Ophthalmic Surgery (2020-2028) ($MN)
  • Table 31 Global Platelet Rich Plasma (PRP) Market Outlook, By Neurosurgery (2020-2028) ($MN)
  • Table 32 Global Platelet Rich Plasma (PRP) Market Outlook, By General Surgery (2020-2028) ($MN)
  • Table 33 Global Platelet Rich Plasma (PRP) Market Outlook, By Dentistry/Periodontal Surgery (2020-2028) ($MN)
  • Table 34 Global Platelet Rich Plasma (PRP) Market Outlook, By Aesthetics (2020-2028) ($MN)
  • Table 35 Global Platelet Rich Plasma (PRP) Market Outlook, By Nerve Injury (2020-2028) ($MN)
  • Table 36 Global Platelet Rich Plasma (PRP) Market Outlook, By Other Applications (2020-2028) ($MN)
  • Table 37 Global Platelet Rich Plasma (PRP) Market Outlook, By Wound Healing (2020-2028) ($MN)
  • Table 38 Global Platelet Rich Plasma (PRP) Market Outlook, By Urology (2020-2028) ($MN)
  • Table 39 Global Platelet Rich Plasma (PRP) Market Outlook, By Oral and Maxillofacial Surgery (2020-2028) ($MN)
  • Table 40 Global Platelet Rich Plasma (PRP) Market Outlook, By Cardiothoracic Surgery (2020-2028) ($MN)
  • Table 41 Global Platelet Rich Plasma (PRP) Market Outlook, By End User (2020-2028) ($MN)
  • Table 42 Global Platelet Rich Plasma (PRP) Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
  • Table 43 Global Platelet Rich Plasma (PRP) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 44 Global Platelet Rich Plasma (PRP) Market Outlook, By Physician's office/Private Practice (2020-2028) ($MN)
  • Table 45 Global Platelet Rich Plasma (PRP) Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 46 Global Platelet Rich Plasma (PRP) Market Outlook, By Cosmetic/Dermatology/Trichology Clinics (2020-2028) ($MN)
  • Table 47 Global Platelet Rich Plasma (PRP) Market Outlook, By Orthopedic Clinics (2020-2028) ($MN)
  • Table 48 Global Platelet Rich Plasma (PRP) Market Outlook, By Ophthalmic Clinics (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.